当前位置: 首页 > 期刊 > 《中国现代医生》 > 2014年第14期 > 正文
编号:12708619
AGR2、Lgr5在结直肠癌中的表达及其临床意义(4)
http://www.100md.com 2014年5月15日 刘丽娜 殷云勤 张兆美 席玉
第1页

    参见附件。

     [12] Leushacke M, Barker N. Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer[J]. Oncogene, 2012, 31(25): 3009-3022.

    [13] Kim HS , Kang SH , Park CH, et al. Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis[J]. Oncology Reports, 2011, 25(3):717-727.

    [14] Ziskin JL, Yaylaoglu M, Dunlap D, et al. In situ validation of an intestinal stem cell signature in colorectal cancer[J]. Gut, 2013, 62(7): 1012-1023.

    [15] Walker F, Odorizzi A, Zhang HH, et al. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines[J]. PLoS One, 2011, 6(7):22733.

    [16] Takahashi H, Nishida N, Ishii H, et al. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum[J]. Ann Surg Oncol, 2011, 18(4): 1166-1174.

    [17] Wu XS, Chen L, Xi HQ. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival[J]. World J Surg Oncol, 2012, 10:244.

    (收稿日期:2014-01-28)

您现在查看是摘要介绍页,详见PDF附件